SK285037B6 - Spôsob výroby 2-aryl-3-aryl-5-halogénpyridínov - Google Patents

Spôsob výroby 2-aryl-3-aryl-5-halogénpyridínov Download PDF

Info

Publication number
SK285037B6
SK285037B6 SK1436-99A SK143699A SK285037B6 SK 285037 B6 SK285037 B6 SK 285037B6 SK 143699 A SK143699 A SK 143699A SK 285037 B6 SK285037 B6 SK 285037B6
Authority
SK
Slovakia
Prior art keywords
compound
group
pyridinyl
formula
mono
Prior art date
Application number
SK1436-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK143699A3 (en
Inventor
Philip J. Pye
Ashok Maliakal
Kai Rossen
Ralph P. Volante
Jess Sager
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9709686.1A external-priority patent/GB9709686D0/en
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of SK143699A3 publication Critical patent/SK143699A3/sk
Publication of SK285037B6 publication Critical patent/SK285037B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00Formation or introduction of functional groups containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/52Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1436-99A 1997-04-18 1998-04-14 Spôsob výroby 2-aryl-3-aryl-5-halogénpyridínov SK285037B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4564297P 1997-04-18 1997-04-18
GBGB9709686.1A GB9709686D0 (en) 1997-05-13 1997-05-13 Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
PCT/US1998/008312 WO1998047871A1 (en) 1997-04-18 1998-04-14 Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors

Publications (2)

Publication Number Publication Date
SK143699A3 SK143699A3 (en) 2000-07-11
SK285037B6 true SK285037B6 (sk) 2006-05-04

Family

ID=26311530

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1436-99A SK285037B6 (sk) 1997-04-18 1998-04-14 Spôsob výroby 2-aryl-3-aryl-5-halogénpyridínov

Country Status (22)

Country Link
EP (1) EP0975596B1 (es)
JP (1) JP3300369B2 (es)
KR (1) KR20010006546A (es)
CN (1) CN1182117C (es)
AT (1) ATE270275T1 (es)
AU (1) AU729730B2 (es)
BR (1) BR9808923B1 (es)
CA (1) CA2287482C (es)
CZ (1) CZ293246B6 (es)
DE (1) DE69824839T2 (es)
EA (1) EA002190B1 (es)
ES (1) ES2223128T3 (es)
HK (1) HK1023771A1 (es)
HR (1) HRP980206B1 (es)
HU (1) HU226999B1 (es)
NZ (1) NZ500390A (es)
PL (1) PL190265B1 (es)
RS (1) RS49901B (es)
SK (1) SK285037B6 (es)
TW (1) TW492959B (es)
UA (1) UA66792C2 (es)
WO (1) WO1998047871A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1394149E (pt) * 1999-01-14 2005-05-31 Lonza Ag Processo para a producao de 1-(6-metilpiridin-3-il)-2-[4-(metilsulfonil)fenil]etanona
KR100446324B1 (ko) * 1999-01-14 2004-08-30 론자 아게 1-(6-메틸피리딘-3-일)-2-[4-(메틸술포닐)페닐]에타논 및이의 제조 방법
JP4773013B2 (ja) * 1999-07-27 2011-09-14 ロンザ アーゲー 1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノンの製造方法
US6566527B1 (en) 1999-07-27 2003-05-20 Merck & Co., Inc. Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-methylsulphonyl)-phenyl]ethanone
JP2003523958A (ja) 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−2の阻害剤、組成物ならびに使用法
JP2001261647A (ja) * 2000-03-22 2001-09-26 Sankio Chemical Co Ltd ピリジン誘導体の製造方法
ES2290157T3 (es) 2000-07-20 2008-02-16 Lauras As Uso de inhibidores de cox-2 como inmunoestimulantes en el tratamiento de vih o sida.
EP2582690B1 (en) * 2010-06-16 2018-07-25 Glenmark Generics Limited Process for preparation of 2, 3-diaryl-5-substituted pyridines and their intermediates
UA114594C2 (uk) * 2010-11-15 2017-07-10 Вірдев Інтермедіейтс Пвт. Лтд. Спосіб одержання селективного інгібітора циклооксигенази-2
CN103204803A (zh) 2012-01-13 2013-07-17 阿尔弗雷德·E·蒂芬巴赫尔有限责任两合公司 用于合成依托考昔的方法
WO2014114352A1 (en) * 2013-01-25 2014-07-31 Synthon Bv Process for making etoricoxib
WO2015036550A1 (en) 2013-09-13 2015-03-19 Synthon B.V. Process for making etoricoxib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH561717A5 (es) * 1971-05-10 1975-05-15 Ciba Geigy Ag
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5686470A (en) * 1995-02-10 1997-11-11 Weier; Richard M. 2, 3-substituted pyridines for the treatment of inflammation
AU699593B2 (en) * 1995-02-13 1998-12-10 G.D. Searle & Co. Substituted isoxazoles for the treatment of inflammation
US5643933A (en) * 1995-06-02 1997-07-01 G. D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US5677318A (en) * 1996-07-11 1997-10-14 Merck Frosst Canada, Inc. Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents
IL127441A (en) * 1996-07-18 2003-02-12 Merck Frosst Canada Inc Substituted pyridines, pharmaceutical compositions comprising them and their use in the preparation of anti-inflammatory medicaments or as selective cyclooxygenase-2 inhibitors

Also Published As

Publication number Publication date
DE69824839T2 (de) 2005-07-07
CZ293246B6 (cs) 2004-03-17
HRP980206B1 (en) 2002-02-28
JP3300369B2 (ja) 2002-07-08
SK143699A3 (en) 2000-07-11
HU226999B1 (en) 2010-04-28
ATE270275T1 (de) 2004-07-15
WO1998047871A1 (en) 1998-10-29
CZ369099A3 (cs) 2000-04-12
RS49901B (sr) 2008-08-07
EP0975596A1 (en) 2000-02-02
NZ500390A (en) 2001-08-31
BR9808923B1 (pt) 2010-08-24
PL190265B1 (pl) 2005-11-30
HUP0003155A2 (hu) 2001-06-28
ES2223128T3 (es) 2005-02-16
HUP0003155A3 (en) 2002-01-28
CN1182117C (zh) 2004-12-29
PL336298A1 (en) 2000-06-19
EA002190B1 (ru) 2002-02-28
HRP980206A2 (en) 1998-12-31
YU53699A (sh) 2001-12-26
CN1260782A (zh) 2000-07-19
CA2287482C (en) 2004-02-17
AU7257198A (en) 1998-11-13
TW492959B (en) 2002-07-01
CA2287482A1 (en) 1998-10-29
AU729730B2 (en) 2001-02-08
KR20010006546A (ko) 2001-01-26
BR9808923A (pt) 2000-08-01
JP2000513018A (ja) 2000-10-03
EA199900948A1 (ru) 2000-04-24
DE69824839D1 (de) 2004-08-05
EP0975596B1 (en) 2004-06-30
HK1023771A1 (en) 2000-09-22
UA66792C2 (uk) 2004-06-15

Similar Documents

Publication Publication Date Title
US6127545A (en) Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors
US6369275B1 (en) Process for making diaryl pyridines useful as cox-2 inhibitors
JP3325263B2 (ja) Cox−2のインヒビターとして有用なジアリールピリジンの製造方法
US6130334A (en) Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors
SK282789B6 (sk) Spôsob výroby fenylheterocyklických zlúčenín a medziprodukt
SK284805B6 (sk) Spôsob syntézy 3,5-disubstituovaných-2-(fenyl alebo pyridyl)-pyridínov
SK285037B6 (sk) Spôsob výroby 2-aryl-3-aryl-5-halogénpyridínov
AU753381B2 (en) Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors
JPH03161458A (ja) α,β―不飽和ケトン類の製法
JPS63239273A (ja) フエニルイミダゾ−ル誘導体
NL7905996A (nl) Werkwijze ter bereiding van benzoxazolylpropionzuur- derivaten.
Abu-Hatab et al. Synthesis and Reactions of Some New 4-Substituted-3-Alkoxy-2-Butenoic Acid Ester Derivatives
CZ200163A3 (en) Process for preparing 2-aminobenzophenone

Legal Events

Date Code Title Description
TC4A Change of owner's name

Owner name: MERCK SHARP & DOHME CORP., RAHWAY, NJ, US

Effective date: 20100203

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20120414